DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Rini BI, Powles T, Atkins MB. et al.
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial.
Lancet 2019;
393: 2404-2415
DOI: 10.1016/s0140-6736(19)30723-8.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.